Hepatic-pulmonary disease
نویسندگان
چکیده
منابع مشابه
Treatment of Hepatic and Pulmonary Hydatidosis with Mebendazole
Mebendazole was given to two patients with multiple hydatidosis of the liver and three patients with multiple hydatidosis of the lungs. They could not be treated surgically because of aduanced diseases. So they wer given a daily dose of 25-40 mg/kg body weight for 9-12 months. Definite clinical result in one patient and some clinical improvements in the size of the liver and clearance of the lu...
متن کاملHydatidosis: experience with hepatic and pulmonary hydatid disease.
From 1989-1992, 35 cases comprising of 20 hepatic and 15 pulmonary hydatid cysts were seen. Four patients with pulmonary hydatid disease had previous or concomitant hepatic hydatidosis compared to no concomitant pulmonary hydatid disease in the hepatic group. Hepatic hydatid disease had a greater tendency to be right sides, infected and calcified. Anaphylactic reactions occurred in 3 of 20 pati...
متن کاملHigh mebendazole doses in pulmonary and hepatic hydatid disease.
Thirty nine children with 71 hydatid cysts were given mebendazole orally in a dose of 100-200 mg/kg/day for 12 weeks and were followed up for a mean (SD) of 63 (24) months. Twenty children (three of them after a second course) were cured and another two avoided at least one operation. No serious side effects of the drug were observed.
متن کاملPulmonary hepatic nodules.
To cite: Talanow R, Hatipoglu US, Graham R. BMJ Case Rep Published online: [please include Day Month Year] doi:10.1136/ bcr-2012-006867 DESCRIPTION A young woman presented with three pulmonary nodules identified in the right lower lobe discovered on an outside CT scan of the abdomen which was performed to investigate right flank pain. The pain was ascribed to urinary tract infection and resolve...
متن کاملPulmonary-Hepatic vascular Disorders (PHD).
Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 862 Hepatopulmonary syndrome . . . . . . . . . . . . . . . . . . 862 Definition . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 862 Staging of severity . . . . . . . . . . . . . . . . . . . . . . . 863 Natural history and outcome . . . . . . . . . . . . . . . . 863 Pathophysiology . . . . . . . . . . . . . . . . . . ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Internal Medicine
سال: 2019
ISSN: 0953-6205
DOI: 10.1016/j.ejim.2018.12.013